Sandu Pharmaceuticals Ltd — Dividend/Bonus, 28-05-2025: Corp. Action

Sandu Pharmaceuticals has announced a board meeting that recommended a dividend of Rs. 0.80 per equity share (8% on face value of Rs. 10) for the financial year ended March 31, 2025. The dividend is subject to shareholder approval at the upcoming Annual General Meeting, with details on the record date and payout to be shared later. This dividend reflects the company’s profitability and offers shareholders a steady income stream.